Department of Cardiology and Angiology, Division of Experimental and Clinical Electrophysiology, University Hospital of Münster, Münster, Germany.
Heart Rhythm. 2011 Sep;8(9):1383-90. doi: 10.1016/j.hrthm.2011.03.051. Epub 2011 Mar 30.
Pulmonary vein (PV) electrical isolation is a therapeutic option in atrial fibrillation (AF). New technologies may reduce the complexity of the procedure.
The aim of the present study was to compare immediate results and short-term efficacy of a new circular ablation catheter (PVAC) with a conventional point-by-point ablation.
The prospective study enrolled 80 consecutive patients with paroxysmal AF or persistent AF, refractory to antiarrhythmic drugs, who were randomized to radiofrequency ablation using duty-cycled bipolar and unipolar radiofrequency by a decapolar circular catheter (PVAC group) or to point-by-point ablation supported by a 3-dimensional mapping system (3D group).
Forty patients per group were included. Mean age was 58 ± 10 years, 64% were male; 55% had paroxysmal AF, 45% had persistent AF. There were no significant differences between groups. Complete electrical isolation was reached in all but 1 PV, which was not isolated in the PVAC group because of phrenic nerve capture. Procedure and fluoroscopy times were lower in the PVAC group: 171 ± 40 minutes vs. 224 ± 27 minutes, P < .001; 26 ± 8 minutes vs. 35 ± 9 minutes, P < .001; respectively. There were no major complications. During a mean follow-up of 254 ± 99 days, 72% in the PVAC group and 68% in the 3D group were free of AF recurrences irrespective of the initial AF type (P = NS).
PVAC represents a safe alternative for PV isolation. It reduces both procedure and fluoroscopy time. The short- and middle-term efficacy is comparable to a conventional point-by-point antral ablation technique.
肺静脉(PV)电隔离是治疗心房颤动(AF)的一种选择。新技术可能会降低手术的复杂性。
本研究旨在比较新的环形消融导管(PVAC)与常规逐点消融的即刻结果和短期疗效。
前瞻性研究纳入了 80 例阵发性 AF 或持续性 AF 患者,这些患者对抗心律失常药物耐药,随机分为使用双极和单极射频的交调式双极和单极射频消融组(PVAC 组)或使用三维标测系统支持的逐点消融组(3D 组)。
每组各有 40 例患者。平均年龄为 58 ± 10 岁,64%为男性;55%为阵发性 AF,45%为持续性 AF。两组间无显著差异。除 1 例因膈神经捕获而未隔离的 PV 外,所有 PV 均达到完全电隔离。PVAC 组的手术和透视时间均较低:171 ± 40 分钟对 224 ± 27 分钟,P <.001;26 ± 8 分钟对 35 ± 9 分钟,P <.001;分别。无重大并发症。在平均 254 ± 99 天的随访期间,PVAC 组 72%和 3D 组 68%的患者无论初始 AF 类型如何均无 AF 复发(P = NS)。
PVAC 是一种安全的 PV 隔离替代方法。它可以降低手术和透视时间。短期和中期疗效与常规的逐点窦房结消融技术相当。